Cencora Inc
XBER:ABG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cencora Inc
XBER:ABG
|
US |
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
PL |
|
Clover Corporation Ltd
ASX:CLV
|
AU |
|
P
|
Procorp SAB de CV
BMV:PROCORPB
|
MX |
|
ITV PLC
LSE:ITV
|
UK |
|
Relatech SpA
MIL:RLT
|
IT |
|
Mizuho Medy Co Ltd
TSE:4595
|
JP |
|
R
|
Ramsay Generale de Sante SA
PAR:GDS
|
FR |
Wall Street
Price Targets
ABG Price Targets Summary
Cencora Inc
According to Wall Street analysts, the average 1-year price target for
ABG
is 375.48 EUR
with a low forecast of 281.74 EUR and a high forecast of 415.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABG's stock price target?
Price Target
375.48
EUR
According to Wall Street analysts, the average 1-year price target for
ABG
is 375.48 EUR
with a low forecast of 281.74 EUR and a high forecast of 415.45 EUR.
What is Cencora Inc's Revenue forecast?
Projected CAGR
8%
For the last 13 years the
compound annual growth rate for
Cencora Inc's revenue is
11%.
The projected
CAGR
for the next 3 years is
8%.
What is Cencora Inc's Operating Income forecast?
Projected CAGR
15%
For the last 13 years the
compound annual growth rate for
Cencora Inc's operating income is
8%.
The projected
CAGR
for the next 3 years is
15%.
What is Cencora Inc's Net Income forecast?
Projected CAGR
40%
For the last 13 years the
compound annual growth rate for
Cencora Inc's net income is
6%.
The projected
CAGR
for the next 3 years is
40%.
